CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 100 filers reported holding CUE BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is 0.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $51,377 | -32.4% | 14,076 | -58.7% | 0.00% | – |
| Q3 2022 | $76,000 | -76.7% | 34,102 | -73.9% | 0.00% | -100.0% |
| Q2 2022 | $326,000 | -62.2% | 130,854 | -26.0% | 0.00% | -66.7% |
| Q1 2022 | $863,000 | +36.8% | 176,756 | +217.1% | 0.00% | +200.0% |
| Q4 2021 | $631,000 | -58.1% | 55,750 | -46.1% | 0.00% | -66.7% |
| Q3 2021 | $1,507,000 | -35.6% | 103,430 | -48.5% | 0.00% | -40.0% |
| Q2 2021 | $2,340,000 | -40.8% | 200,868 | -38.0% | 0.01% | -50.0% |
| Q1 2021 | $3,952,000 | -2.8% | 323,958 | -0.3% | 0.01% | -16.7% |
| Q4 2020 | $4,066,000 | -9.9% | 325,000 | +8.4% | 0.01% | -25.0% |
| Q3 2020 | $4,512,000 | -21.1% | 299,817 | +28.4% | 0.02% | -42.9% |
| Q2 2020 | $5,722,000 | – | 233,451 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 829,042 | $9,376,000 | 5.61% |
| P.A.W. CAPITAL CORP | 120,000 | $1,357,000 | 1.24% |
| Nantahala Capital Management | 2,539,700 | $28,724,000 | 1.01% |
| Slate Path Capital LP | 1,483,619 | $16,780,000 | 0.88% |
| SANDERS MORRIS HARRIS LLC | 359,113 | $4,416,000 | 0.76% |
| APOGEM CAPITAL LLC | 62,295 | $705,000 | 0.46% |
| Robertson Stephens Wealth Management, LLC | 478,500 | $5,411,000 | 0.46% |
| Bleichroeder LP | 200,000 | $2,262,000 | 0.35% |
| ADVISORY RESEARCH INC | 257,225 | $2,909,000 | 0.23% |
| Granite Point Capital Management, L.P. | 110,000 | $1,244,000 | 0.21% |